MagForce AG Seeks Trademark Protection for Nanotherm Technology

Strategic Insights -

MagForce AG, a German company, is seeking trademark protection for its "Nanotherm" technology, which involves the use of magnetic nanoparticles to treat cancer and other diseases. The application, made through The Marbury Law Group, PLLC, includes a wide range of goods and services, including diagnostic agents, pharmaceutical preparations, contrasting agents, and medical services. The technology has the potential to revolutionize the treatment of cancer and other diseases, and MagForce AG is seeking to protect its intellectual property rights.

Key Takeaways:

  • The trademark application for "Nanotherm" was made available to the public on September 28, 2025, with a serial number of 86297568.
  • The application includes a wide range of goods and services, including diagnostic agents, pharmaceutical preparations, contrasting agents, and medical services.
  • The technology involves the use of magnetic nanoparticles to treat cancer and other diseases, and has the potential to revolutionize the treatment of cancer and other diseases.
  • MagForce AG is seeking to protect its intellectual property rights through the trademark application.
  • The application includes goods and services for use in industry and research, including magnetic nanoparticles, superparamagnetic nanoparticles, and nanoparticles for use in therapy methods, thermotherapy methods, and hyperthermia methods.

Statistics:

  • The trademark application was made available to the public on September 28, 2025.
  • The application has a serial number of 86297568.
  • The international trademark goods and services class codes for this trademark application are 001, 005, 010, 042, and 044.
  • The trademark application includes goods and services for use in 17 different areas, including diagnostic agents, pharmaceutical preparations, contrasting agents, and medical services.

Sources:

  • NewsRx
  • MagForce AG
  • The Marbury Law Group, PLC
  • US Patent and Trademark Office (TP/DOC: announced Sept. 28, 2025)